Page 6 - மருந்து கட்டுப்பாடு அதிகாரம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

PETALING JAYA: The Sinopharm and Johnson & Johnson Covid-19 vaccines have been granted conditional approval for use in the country’s National Covid-19 Immunisation Programme, says the Health Ministry. In a statement, the ministry said the Drug Control Authority (DCA) made the decision at a meeting on Friday (July 16). “This conditional registration approval requires information on the quality, safety and effectiveness of the vaccine product to be monitored and evaluated based on the latest data from time to time. “It is to ensure that the benefit over risk for the vaccines remain positive,” it said. The ministry said it strives to combat the pandemic by ensuring adequate supply of vaccines that have been evaluated for quality, safety and effectiveness by the National Pharmaceutical Regulatory Division and approved by the DCA.

Malaysia generalJanssen pharmaceuticaJohnson covidDrug control authorityHealth ministryImmunisation programmeNational pharmaceutical regulatory divisionNational covidமருந்து கட்டுப்பாடு அதிகாரம்ஆரோக்கியம் அமைச்சகம்நோய்த்தடுப்பு ப்ரோக்ராம்தேசிய மருந்து ஒழுங்குமுறை பிரிவு